Lista de obras - Ekaterina Safroneeva - Dominio Público Uruguay

A cysteine-free firefly luciferase retains luminescence activity

scientific article published on 01 January 2000

A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families

artículo científico publicado en 2016

A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.

artículo científico publicado en 2013

Activity assessment of eosinophilic esophagitis.

artículo científico

Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2014

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

artículo científico publicado en 2017

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2015

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)

scientific article published on 31 January 2018

Colorectal polypectomy during insertion and withdrawal or only during withdrawal? A randomized controlled trial

scientific article published on 28 August 2012

Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis

artículo científico publicado en 2016

Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner

artículo científico publicado en 2013

Dendritic cells derived from murine colonic mucosa have unique functional and phenotypic characteristics

scientific article published on 01 June 2007

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis

artículo científico publicado en 2014

Eosinophile Oesophagitis.

artículo científico publicado en 2017

Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.

artículo científico publicado en 2016

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

artículo científico publicado en 2018

Eosinophilic esophagitis: latest insights from diagnosis to therapy

scientific article published on 15 May 2018

Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings

artículo científico publicado en 2014

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity

artículo científico publicado en 2015

Eosinophils in the gastrointestinal tract: friends or foes?

artículo científico publicado en 2012

Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study

artículo científico

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment

artículo científico publicado en 2016

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

artículo científico publicado en 2013

First-line therapies in inflammatory bowel disease

artículo científico

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2018

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review

scientific article published on 14 June 2018

High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients

artículo científico publicado en 2013

How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

artículo científico publicado en 2015

How to measure disease activity in eosinophilic esophagitis

artículo científico

Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease

artículo científico publicado en 2015

Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

artículo científico publicado en 2018

Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept

artículo científico

Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients

scientific article published on 11 June 2018

Patient-Reported Outcomes in Eosinophilic Esophagitis and Achalasia.

artículo científico publicado en 2016

Pharmacologic Treatment of Eosinophilic Esophagitis: An Update

artículo científico publicado en 2017

Placebo and other interventions in asthma ⬇️

artículo científico publicado el 13 de octubre de 2011

Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2016

Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up

artículo científico publicado en 2016

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

artículo científico publicado en 2012

Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.

artículo científico publicado en 2014

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis

artículo científico publicado en 2015

Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.

artículo científico publicado en 2015

The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma.

artículo científico publicado en 2005

Therapy of steroid-resistant inflammatory bowel disease

artículo científico publicado en 2012

Treatment of fibrostenotic and fistulizing Crohn's disease

artículo científico publicado en 2012

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course

scientific article published on 01 November 2018

Lista de obras de Ekaterina Safroneeva

A cysteine-free firefly luciferase retains luminescence activity

A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families

A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.

Activity assessment of eosinophilic esophagitis.

Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)

Colorectal polypectomy during insertion and withdrawal or only during withdrawal? A randomized controlled trial

Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis

Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner

Dendritic cells derived from murine colonic mucosa have unique functional and phenotypic characteristics

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis

Eosinophile Oesophagitis.

Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Eosinophilic esophagitis: latest insights from diagnosis to therapy

Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity

Eosinophils in the gastrointestinal tract: friends or foes?

Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

First-line therapies in inflammatory bowel disease

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review

High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients

How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

How to measure disease activity in eosinophilic esophagitis

Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease

Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept

Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients

Patient-Reported Outcomes in Eosinophilic Esophagitis and Achalasia.

Pharmacologic Treatment of Eosinophilic Esophagitis: An Update

Placebo and other interventions in asthma ⬇️

Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort

Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis

Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.

The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma.

Therapy of steroid-resistant inflammatory bowel disease

Treatment of fibrostenotic and fistulizing Crohn's disease

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course